Renal Cyst Development in Mice with Conditional Inactivation of the Von Hippel-Lindau Tumor Suppressor

Overview

Journal Cancer Res

Specialty Oncology

Date 2006 Mar 3

PMID 16510575

Citations 217

Authors

Erinn B Rankin

John E Tomaszewski

Volker H Haase

Affiliations

Soon will be listed here.

Abstract

Inactivation of the von Hippel-Lindau tumor suppressor, pVHL, is associated with both hereditary and sporadic renal cysts and renal cell carcinoma, which are commonly thought to arise from the renal proximal tubule. pVHL regulates the protein stability of hypoxia-inducible factor (HIF)-alpha subunits and loss of pVHL function leads to HIF stabilization. The role of HIF in the development of VHL-associated renal lesions remains to be determined. To investigate the functional consequences of pVHL inactivation and the role of HIF signaling in renal epithelial cells, we used the phosphoenolpyruvate carboxykinase (PEPCK) promoter to generate transgenic mice in which Cre-recombinase is expressed in the renal proximal tubule and in hepatocytes. We found that conditional inactivation of VHL in PEPCK-Cre mutants resulted in renal cyst development that was associated with increased erythropoietin levels and polycythemia. Increased expression of the HIF target gene erythropoietin was limited to the liver, whereas expression of carbonic anhydrase 9 and multidrug resistance gene 1 was up-regulated in the renal cortex of mutant mice. Inactivation of the HIF-alpha binding partner, arylhydrocarbon receptor nuclear translocator (Arnt), but not Hif-1alpha, suppressed the development of renal cysts. Here, we present the first mouse model of VHL-associated renal disease that will provide a basis for further genetic studies to define the molecular events that are required for the progression of VHL-associated renal cysts to clear cell renal cell carcinoma.

Citing Articles

TEAD1 Prevents Necroptosis and Inflammation in Cisplatin-Induced Acute Kidney Injury Through Maintaining Mitochondrial Function.

Tran M, Jiao B, Du H, Zhou D, Yechoor V, Wang Y Int J Biol Sci. 2025; 21(2):565-578.

PMID: 39781453 PMC: 11705647. DOI: 10.7150/ijbs.104335.

Dysregulation of ubiquitination modification in renal cell carcinoma.

You H, Zhang H, Jin X, Yan Z Front Genet. 2025; 15:1453191.

PMID: 39748950 PMC: 11693700. DOI: 10.3389/fgene.2024.1453191.

Toward a CRISPR-based mouse model of -deficient clear cell kidney cancer: Initial experience and lessons learned.

Stransky L, Gao W, Schmidt L, Bi K, Ricketts C, Ramesh V Proc Natl Acad Sci U S A. 2024; 121(41):e2408549121.

PMID: 39365820 PMC: 11474080. DOI: 10.1073/pnas.2408549121.

Sustained alterations in proximal tubule gene expression in primary culture associate with HNF4A loss.

Telang A, Ference-Salo J, McElliott M, Chowdhury M, Beamish J Sci Rep. 2024; 14(1):22927.

PMID: 39358473 PMC: 11447228. DOI: 10.1038/s41598-024-73861-3.

PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma.

Walton J, Ng A, Arevalo K, Apostoli A, Meens J, Karamboulas C Nat Commun. 2024; 15(1):8232.

PMID: 39300069 PMC: 11413393. DOI: 10.1038/s41467-024-52507-y.

References

Sikri K, Foster C, Bloomfield F, Marshall R . Localization by immunofluorescence and by light- and electron-microscopic immunoperoxidase techniques of Tamm-Horsfall glycoprotein in adult hamster kidney. Biochem J. 1979; 181(3):525-32. PMC: 1161191. DOI: 10.1042/bj1810525. View

Schulte B, SPICER S . Histochemical evaluation of mouse and rat kidneys with lectin-horseradish peroxidase conjugates. Am J Anat. 1983; 168(3):345-62. DOI: 10.1002/aja.1001680308. View

Doetschman T, Gregg R, Maeda N, Hooper M, Melton D, Thompson S . Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature. 1987; 330(6148):576-8. DOI: 10.1038/330576a0. View

Solomon D, Schwartz A . Renal pathology in von Hippel-Lindau disease. Hum Pathol. 1988; 19(9):1072-9. DOI: 10.1016/s0046-8177(88)80089-3. View

Kragel P, Walther M, Pestaner J, Filling-Katz M . Simple renal cysts, atypical renal cysts, and renal cell carcinoma in von Hippel-Lindau disease: a lectin and immunohistochemical study in six patients. Mod Pathol. 1991; 4(2):210-4. View

Laird P, Zijderveld A, Linders K, Rudnicki M, Jaenisch R, Berns A . Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 1991; 19(15):4293. PMC: 328579. DOI: 10.1093/nar/19.15.4293. View

Semenza G, Koury S, Nejfelt M, Gearhart J, Antonarakis S . Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc Natl Acad Sci U S A. 1991; 88(19):8725-9. PMC: 52582. DOI: 10.1073/pnas.88.19.8725. View

Beale E, Clouthier D, Hammer R . Cell-specific expression of cytosolic phosphoenolpyruvate carboxykinase in transgenic mice. FASEB J. 1992; 6(15):3330-7. DOI: 10.1096/fasebj.6.15.1281456. View

Latif F, Tory K, Gnarra J, Yao M, Duh F, Orcutt M . Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993; 260(5112):1317-20. DOI: 10.1126/science.8493574. View

10.

Maxwell P, Osmond M, Pugh C, Heryet A, Nicholls L, Tan C . Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int. 1993; 44(5):1149-62. DOI: 10.1038/ki.1993.362. View

11.

Patel Y, Yun J, Liu J, McGrane M, Hanson R . An analysis of regulatory elements in the phosphoenolpyruvate carboxykinase (GTP) gene which are responsible for its tissue-specific expression and metabolic control in transgenic mice. J Biol Chem. 1994; 269(8):5619-28. View

12.

Witzgall R, Brown D, Schwarz C, Bonventre J . Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest. 1994; 93(5):2175-88. PMC: 294357. DOI: 10.1172/JCI117214. View

13.

Gnarra J, Tory K, Weng Y, Schmidt L, Wei M, Li H . Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet. 1994; 7(1):85-90. DOI: 10.1038/ng0594-85. View

14.

Macgregor G, Zambrowicz B, Soriano P . Tissue non-specific alkaline phosphatase is expressed in both embryonic and extraembryonic lineages during mouse embryogenesis but is not required for migration of primordial germ cells. Development. 1995; 121(5):1487-96. DOI: 10.1242/dev.121.5.1487. View

15.

Walther M, Lubensky I, Venzon D, Zbar B, Linehan W . Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol. 1995; 154(6):2010-4; discussion 2014-5. View

16.

Iliopoulos O, Kibel A, Gray S, Kaelin Jr W . Tumour suppression by the human von Hippel-Lindau gene product. Nat Med. 1995; 1(8):822-6. DOI: 10.1038/nm0895-822. View

17.

Motzer R, Bander N, Nanus D . Renal-cell carcinoma. N Engl J Med. 1996; 335(12):865-75. DOI: 10.1056/NEJM199609193351207. View

18.

Bronson S, Plaehn E, Kluckman K, Hagaman J, Maeda N, SMITHIES O . Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci U S A. 1996; 93(17):9067-72. PMC: 38596. DOI: 10.1073/pnas.93.17.9067. View

19.

Gnarra J, Zhou S, Merrill M, Wagner J, Krumm A, Papavassiliou E . Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci U S A. 1996; 93(20):10589-94. PMC: 38197. DOI: 10.1073/pnas.93.20.10589. View

20.

Iliopoulos O, Levy A, Jiang C, Kaelin Jr W, Goldberg M . Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci U S A. 1996; 93(20):10595-9. PMC: 38198. DOI: 10.1073/pnas.93.20.10595. View